Attenuation of bleomycin induced pulmonary fibrosis in mice using the heme oxygenase inhibitor Zn-deuteroporphyrin IX-2,4-bisethylene glycol

Atzori L; Chua F; Dunsmore S E; Willis D; Barbarisi M; McAnulty R J; Laurent G J; Atzori, L; Chua, F; Dunsmore, S E; Willis, D; Barbarisi, M; McAnulty, R J; Laurent, G J
March 2004
Thorax;Mar2004, Vol. 59 Issue 3, p217
Academic Journal
journal article
Background: Pulmonary fibrosis is associated with a poor prognosis. The pathogenesis of fibrotic lung disorders remains unclear, but the extent of tissue damage due to the persistent presence of oxidants or proteases is believed to be important. The heme degrading enzyme heme oxygenase (HO) has been found to be expressed in experimental fibrosis, and generation of free iron and carbon monoxide (CO) by HO has been implicated in oxidant induced lung damage. A study was undertaken to examine the effects of the HO inhibitor Zn-deuteroporphyrin-IX-2,4-bisethylene glycol (Zndtp) on the development of pulmonary fibrosis in the bleomycin model of lung injury and repair.Methods: Zndtp (10 micro mol/kg) was administered subcutaneously twice daily to mice 1 week following the intratracheal instillation of 0.025 U bleomycin. Animals were killed 10 or 21 days after bleomycin instillation and indices of lung damage and fibrosis were evaluated.Results: Bleomycin treatment induced pulmonary cytotoxicity, increased levels of active transforming growth factor beta (TGF-beta), enhanced lung collagen accumulation, and decreased glutathione content. Zndtp administration significantly attenuated these indices.Conclusions: Administration of Zndtp in the bleomycin model resulted in appreciable alveolar cytoprotection and amelioration of pulmonary fibrosis. This molecule and its analogues may warrant further consideration in the treatment of acute lung injury and fibrotic lung disorders.


Related Articles

  • mTOR Overactivation and Compromised Autophagy in the Pathogenesis of Pulmonary Fibrosis. Gui, Yao-Song; Wang, Lianmei; Tian, Xinlun; Li, Xue; Ma, Aiping; Zhou, Weixun; Zeng, Ni; Zhang, Ji; Cai, Baiqiang; Zhang, Hongbing; Chen, Jing-Yu; Xu, Kai-Feng // PLoS ONE;9/18/2015, Vol. 10 Issue 9, p1 

    The mammalian target of rapamycin (mTOR) signaling pathway in pulmonary fibrosis was investigated in cell and animal models. mTOR overactivation in alveolar epithelial cells (AECs) was achieved in the conditional and inducible Tsc1 knock-down mice SPC-rtTA/TetO-Cre/Tsc1fx/+ (STT). Doxycycline...

  • Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis. Tadashi Senoo; Noboru Hattori; Takuya Tanimoto; Makoto Furonaka; Nobuhisa Ishikawa; Kazunori Fujitaka; Yoshinori Haruta; Hiroshi Murai; Akihito Yokoyama; Nobuoki Kohno // Thorax;Apr2010, Vol. 65 Issue 4, p334 

    Background and aim There is a growing body of evidence demonstrating that plasminogen activator inhibitor-1 (PAI-1) is involved in the progression of pulmonary fibrosis. In fact, PAI-1 knockout mice are protected from bleomycin-induced pulmonary fibrosis. This study was conducted to determine...

  • Pharmacological inhibition of leukotrienes in an animal model of bleomycin-induced acute lung injury. Failla, Marco; Genovese, Tiziana; Mazzon, Emanuela; Gili, Elisa; Muià, Carmelo; Sortino, Mariangela; Crimi, Nunzio; Caputi, Achille P.; Cuzzocrea, Salvatore; Vancheri, Carlo // Respiratory Research;2006, Vol. 7, p137 

    Leukotrienes are increased locally in idiopathic pulmonary fibrosis. Furthermore, a role for these arachidonic acid metabolites has been thoroughly characterized in the animal bleomycin model of lung fibrosis by using different gene knock-out settings. We investigated the efficacy of...

  • Fasudil, a Rho-Kinase Inhibitor, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice. Chunguo Jiang; Hui Huang; Jia Liu; Yanxun Wang; Zhiwei Lu; Zuojun Xu // International Journal of Molecular Sciences;Jul2012, Vol. 13 Issue 7, p8293 

    The mechanisms underlying the pathogenesis of idiopathic pulmonary fibrosis (IPF) involve multiple pathways, such as inflammation, epithelial mesenchymal transition, coagulation, oxidative stress, and developmental processes. The small GTPase, RhoA, and its target protein, Rho-kinase (ROCK), may...

  • Suppression of Expression of Heat Shock Protein 70 by Gefitinib and Its Contribution to Pulmonary Fibrosis. Namba, Takushi; Tanaka, Ken-Ichiro; Hoshino, Tatsuya; Azuma, Arata; Mizushima, Tohru // PLoS ONE;2011, Vol. 6 Issue 11, p1 

    Drug-induced interstitial lung disease (ILD), particularly pulmonary fibrosis, is of serious clinical concern. Gefitinib, a tyrosine kinase inhibitor of the epidermal growth factor receptor (EGFR), is beneficial as a drug for treating non-small cell lung cancer; however, this drug induces ILD...

  • Passion fruit peel extract attenuates bleomycin-induced pulmonary fibrosis in mice. Chilakapati, Shanmuga Reddy; Serasanambati, Mamatha; Manikonda, Pavan Kumar; Chilakapati, Damodar Reddy; Watson, Ronald Ross // Canadian Journal of Physiology & Pharmacology;Aug2014, Vol. 92 Issue 8, p631 

    Idiopathic pulmonary fibrosis is a progressive fatal lung disease characterized by excessive collagen deposition, with no effective treatments. We investigated the efficacy of natural products with high anti-inflammatory activity, such as passion fruit peel extract (PFPE), in a mouse model of...

  • Soluble epoxide hydrolase inhibitor 1-trifluoromethoxyphenyl-3- (1-propionylpiperidin-4-yl) urea attenuates bleomycin-induced pulmonary fibrosis in mice. Zhou, Yong; Sun, Guo-Ying; Liu, Tian; Duan, Jia-Xi; Zhou, Hui-Fang; Lee, Kin; Hammock, Bruce; Fang, Xiang; Jiang, Jian-Xin; Guan, Cha-Xiang // Cell & Tissue Research;Feb2016, Vol. 363 Issue 2, p399 

    Epoxyeicosatrienoic acids (EETs), the metabolites of arachidonic acid derived from the cytochrome P450 (CYP450) epoxygenases, are mainly metabolized by soluble epoxide hydrolase (sEH) to their corresponding diols. EETs but not their diols, have anti-inflammatory properties and inhibition of sEH...

  • A pivotal role of cytosolic phospholipase A2 in bleomycin-induced pulmonary fibrosis. Nagase, Takahide; Uozumi, Naonori; Ishii, Satoshi; Kita, Yoshihiro; Yamamoto, Hiroshi; Ohga, Eijiro; Ouchi, Yasuyoshi; Shimizu, Takao // Nature Medicine;May2002, Vol. 8 Issue 5, p480 

    Pulmonary fibrosis is an interstitial disorder of the lung parenchyma whose mechanism is poorly understood. Potential mechanisms include the infiltration of inflammatory cells to the lungs and the generation of pro-inflammatory mediators. In particular, idiopathic pulmonary fibrosis is a...

  • Inhibition of Plasminogen Activator Inhibitor-1 Attenuates Transforming Growth Factor-β-Dependent Epithelial Mesenchymal Transition and Differentiation of Fibroblasts to Myofibroblasts. Omori, Keitaro; Hattori, Noboru; Senoo, Tadashi; Takayama, Yusuke; Masuda, Takeshi; Nakashima, Taku; Iwamoto, Hiroshi; Fujitaka, Kazunori; Hamada, Hironobu; Kohno, Nobuoki // PLoS ONE;2/9/2016, Vol. 11 Issue 2, p1 

    Transforming growth factor-β (TGF-β) is central during the pathogenesis of pulmonary fibrosis, in which the plasminogen activator inhibitor-1 (PAI-1) also has an established role. TGF-β is also known to be the strongest inducer of PAI-1. To investigate the link between PAI-1 and...


Read the Article


Sign out of this library

Other Topics